Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Bupivacaine concentrations in lumbar cerebrospinal fluid in patients with failed spinal anaesthesia
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1196725
Author(s) Steiner, L A; Hauenstein, L; Ruppen, W; Hampl, K F; Seeberger, M D
Author(s) at UniBasel Steiner, Luzius A.
Seeberger-Stucky, Manfred
Year 2009
Title Bupivacaine concentrations in lumbar cerebrospinal fluid in patients with failed spinal anaesthesia
Journal BJA : British journal of anaesthesia
Volume 102
Number 6
Pages / Article-Number 839-44
Keywords anaesthetic techniques, subarachnoid, anaesthetics local, bupivacaine, cerebrospinal fluid
Abstract BACKGROUND: Spinal anaesthesia (SA) has high success rates. However, inadequate block after SA has been reported even in the absence of technical problems. Various mechanisms for failed SA (FSA) have been proposed, but reports of cerebrospinal fluid (CSF) concentrations of local anaesthetics (LA) after FSA are scarce. We report lumbar CSF concentrations of bupivacaine in 20 patients in whom adequate block after subarachnoid injection failed to develop. METHODS: All patients with inadequate block after subarachnoid injection of plain bupivacaine 0.5% and in whom a second subarachnoid injection of LA was to be performed as a rescue technique were eligible for entry into this study. A CSF sample was withdrawn immediately before injection of the second dose of LA. Patients in whom failure was obviously due to technical problems or inadequate dosage were excluded. Bupivacaine concentrations were assessed with high-performance liquid chromatography. RESULTS: During the study period of 15 months, 2600 spinal anaesthetics were performed. The failure rate was 2.7% (71 patients). In 20 patients (0.77%), CSF concentrations of bupivacaine were determined, which ranged from 3.36 to 1020 microg ml(-1). CONCLUSIONS: Inadequate CSF concentration of LA is a common reason for FSA. However, in 12 of our 20 patients, concentrations were above 73 microg ml(-1), a concentration that should lead to an adequate block. In these patients, maldistribution of bupivacaine could be responsible for FSA. In view of the absence of sufficient block, despite adequate lumbar CSF concentrations of bupivacaine, concerns about neurotoxicity with repeat injections may be warranted.
Publisher Oxford University Press
ISSN/ISBN 0007-0912
edoc-URL http://edoc.unibas.ch/dok/A6006888
Full Text on edoc No
Digital Object Identifier DOI 10.1093/bja/aep050
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/19329469
ISI-Number WOS:000266344500019
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.351 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
27/04/2024